Rising prevalence rates of obesity-associated cardiometabolic disorders allied to ageing
populations are driving increases in cardiovascular morbidity and mortality. These adverse …

Cardiovascular-kidney-metabolic health reflects the interplay among metabolic risk factors,
chronic kidney disease, and the cardiovascular system and has profound impacts on …

The ongoing obesity epidemic represents a global public health crisis that contributes to
poor health outcomes, reduced quality of life, and> 2.8 million deaths each year. Obesity is …

Abstract Purpose of Review To summarize research from the last 5 years on the effects of
weight loss treatments, including lifestyle changes, anti-obesity medications, and bariatric …

Context The worldwide rise in the prevalence of cardiometabolic disease, and the
introduction of therapeutic options for treating metabolic disease that also lower …

The prevalence of chronic diseases is rising due to contemporary sedentary lifestyles, poor
eating habits, and increased survival rates after cardiovascular events. Conditions such as …

Cardiometabolic risk encompasses a cluster of risk factors that may predispose individuals
to cardiovascular disease and type 2 diabetes. These risk factors, some of which are …

Diabetes, of which type 2 diabetes accounts for approximately 90% of cases, is a major
preventable risk factor for cardiovascular disease that has reached pandemic proportions …

The prevalence of obesity has increased globally over the last 2 decades. Although the body
mass index has been a convenient and simple index of obesity at the population level …

Improved understanding of the interrelated nature of cardiovascular, kidney and metabolic
(CKM) health, the development of novel risk prediction equations, and the availability of …